Abbott India Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.130x

Abbott India Limited cash flow conversion efficiency. Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.22 Billion ≈ $56.45 Million USD) by net assets (Rs40.11 Billion ≈ $433.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Abbott India Limited (2005–2025)

Cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Abbott India Limited (ABBOTINDIA) stock price for real-time trading data and today's change.

Abbott India Limited Cash Flow Conversion Ratio Explained

Abbott India Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Abbott India Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency. Also see Abbott India Limited (ABBOTINDIA) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Essential Properties Realty Trust Inc
NYSE:EPRT
0.023x
Rayonier Inc
NYSE:RYN
0.116x
Amdocs Limited
F:AOS
0.064x
TXNM Energy, Inc.
NYSE:TXNM
0.019x
Sam Yang Foods
KO:003230
0.037x
Reinet Investments S.C.A
AS:REINA
0.036x
News Corp B
NASDAQ:NWS
0.024x
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX
-0.165x

Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. Review Abbott India Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs42.33 Billion
≈ $457.80 Million
Rs10.12 Billion
≈ $109.43 Million
0.239x -27.10%
2024-03-31 Rs36.99 Billion
≈ $400.02 Million
Rs12.13 Billion
≈ $131.16 Million
0.328x +17.02%
2023-03-31 Rs31.89 Billion
≈ $344.83 Million
Rs8.93 Billion
≈ $96.62 Million
0.280x -16.63%
2022-03-31 Rs28.20 Billion
≈ $304.95 Million
Rs9.48 Billion
≈ $102.49 Million
0.336x +20.33%
2021-03-31 Rs26.02 Billion
≈ $281.41 Million
Rs7.27 Billion
≈ $78.59 Million
0.279x +8.47%
2020-03-31 Rs24.32 Billion
≈ $262.98 Million
Rs6.26 Billion
≈ $67.71 Million
0.257x +3.61%
2019-03-31 Rs20.09 Billion
≈ $217.22 Million
Rs4.99 Billion
≈ $53.98 Million
0.248x +175.47%
2018-03-31 Rs16.93 Billion
≈ $183.07 Million
Rs1.53 Billion
≈ $16.51 Million
0.090x -59.27%
2017-03-31 Rs13.87 Billion
≈ $149.99 Million
Rs3.07 Billion
≈ $33.22 Million
0.222x +6.50%
2016-03-31 Rs11.96 Billion
≈ $129.30 Million
Rs2.49 Billion
≈ $26.89 Million
0.208x -9.21%
2015-03-31 Rs9.38 Billion
≈ $101.39 Million
Rs2.15 Billion
≈ $23.23 Million
0.229x +53.60%
2014-03-31 Rs8.33 Billion
≈ $90.09 Million
Rs1.24 Billion
≈ $13.44 Million
0.149x -4.81%
2013-03-31 Rs6.47 Billion
≈ $69.96 Million
Rs1.01 Billion
≈ $10.96 Million
0.157x +254.26%
2012-03-31 Rs5.44 Billion
≈ $58.85 Million
Rs240.66 Million
≈ $2.60 Million
0.044x -70.68%
2011-03-31 Rs3.05 Billion
≈ $33.03 Million
Rs460.64 Million
≈ $4.98 Million
0.151x +10.24%
2010-03-31 Rs2.72 Billion
≈ $29.37 Million
Rs371.57 Million
≈ $4.02 Million
0.137x -65.29%
2009-03-31 Rs2.21 Billion
≈ $23.93 Million
Rs872.13 Million
≈ $9.43 Million
0.394x +196.26%
2008-03-31 Rs2.31 Billion
≈ $24.98 Million
Rs307.40 Million
≈ $3.32 Million
0.133x -19.72%
2007-03-31 Rs2.46 Billion
≈ $26.58 Million
Rs407.40 Million
≈ $4.41 Million
0.166x -2.57%
2006-03-31 Rs2.16 Billion
≈ $23.41 Million
Rs368.20 Million
≈ $3.98 Million
0.170x -53.15%
2005-03-31 Rs1.88 Billion
≈ $20.36 Million
Rs683.70 Million
≈ $7.39 Million
0.363x --

About Abbott India Limited

NSE:ABBOTINDIA India Drug Manufacturers - Specialty & Generic
Market Cap
$5.93 Billion
Rs548.23 Billion INR
Market Cap Rank
#3092 Global
#138 in India
Share Price
Rs25800.00
Change (1 day)
-0.08%
52-Week Range
Rs25030.00 - Rs30205.00
All Time High
Rs35670.00
About

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more